Goldstein, Steven, MD

placeholder image

visualizations

Publications in VIVO

Co-author Network

Goldstein, Steven, MD
Close

research areas

Most Recent Publications

2020

Role of Post-Allogeneic Hematopoietic Stem Cell Transplantation Low-Dose Azacitidine for Prevention of Relapse in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Retrospective Analysis. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. S126-S127.
2019

Eltrombopag for Treating Thrombocytopenia after Allogeneic Stem Cell Transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 25:1320-1324.
Full Text via DOI: 10.1016/j.bbmt.2019.01.027 PMID: 30710685
2019

Increased bone marrow CD56(bright) natural killer cells at 30 days after allogeneic stem cell transplantation associated with adverse patient outcome. BONE MARROW TRANSPLANTATION. 924-927.
Full Text via DOI: 10.1038/s41409-018-0407-y PMID: 30563982
2019

Aggressive Leukemic Non-Nodal Mantle Cell Lymphoma With P53 Gene Rearrangement/Mutation is Highly Responsive to Rituximab/Ibrutinib Combination Therapy. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 19:E93-E97.
Full Text via DOI: 10.1016/j.clml.2018.11.007 PMID: 30559058
2018

Addition of Cladribine: Improving Standard of Care in Newly Diagnosed Acute Myeloid Leukemia. BLOOD.
Full Text via DOI: 10.1182/blood-2018-99-120285
2018

Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation: Case report and review of the literature. TRANSPLANT INFECTIOUS DISEASE.
Full Text via DOI: 10.1111/tid.12879 PMID: 29512846
2018

Aggressive Leukemic Non-Nodal Mantle Cell Lymphoma with P53 Gene Rearrangement/Mutation is Highly Responsive to Rituximab/Ibrutinib Combination Therapy. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. S253-S254.
2018

Eltrombopag Treatment for Primary and Secondary Thrombocytopenia Post Allogeneic and Autologous Stem Cell Transplantation is Effective and Safe. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. S343-S344.
2018

Post-Transplant Low-Dose Azacitidine Can Improve Overall Survival in AML/MDS Patients and is Associated with Decrease Risks of Severe Acute and Chronic Gvhd. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. S327-S327.
2018

Residual Leukemia in the Bone Marrow and/or Peripheral Blood on Day 7 of Blinatumomab Therapy Predicts Response in B-Cell Acute Lymphoblastic Leukemia. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. S237-S237.
2018

Use of Nitazoxanide, an Anti-Parasitic Drug, for Management of Norovirus Ileo-Colitis in an Allogeneic Stem Cell Transplant Patient. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. S394-S395.
2017

Use of allogeneic apheresis stem cell products as an interlaboratory proficiency challenge. TRANSFUSION. 57:1543-1554.
Full Text via DOI: 10.1111/trf.14107 PMID: 28370131

Full Name

Steven Goldstein, MD

Preferred Title

Medical Director of the Blood and Marrow Transplant Center, Hematology Oncologist